Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

ClinicalTrials.gov ID: NCT01457677

Public ClinicalTrials.gov record NCT01457677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 3, 2026, 8:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This multi-center, randomized, double-blind, placebo-controlled, parallel-group study will investigate the efficacy and safety of RO4995819 as adjunctive therapy in patients with major depressive disorder having inadequate response to ongoing antidepressant treatment. Patients will be randomized to receive once daily doses of 5 mg, 15 or 30 mg of RO4995819 or matching placebo. The anticipated time on study treatment is 6 weeks.

Study identification

NCT ID
NCT01457677
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
357 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2011 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Jun 2014 (Actual)
Last update posted
Nov 2, 2016

2011 – 2014

United States locations

U.S. sites
43
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Not listed Phoenix Arizona 85381 —
Not listed Oakland California 94607 —
Not listed Redlands California 92374 —
Not listed San Diego California 92103 —
Not listed Stanford California 94305 —
Not listed Torrance California 90502 —
Not listed Victorville California 92295 —
Not listed Denver Colorado 80239 —
Not listed Coral Springs Florida 33067 —
Not listed Gainsville Florida 32607 —
Not listed Jacksonville Florida 32216 —
Not listed Lauderhill Florida 33319 —
Not listed North Miami Florida 33161 —
Not listed Ocala Florida 34471 —
Not listed Atlanta Georgia 30308 —
Not listed Roswell Georgia 30076 —
Not listed Smyrna Georgia 30080 —
Not listed Chicago Illinois 60612-3244 —
Not listed Prairie Village Kansas 66206 —
Not listed Wichita Kansas 67214 —
Not listed Baltimore Maryland 21208 —
Not listed Boston Massachusetts 02114 —
Not listed Watertown Massachusetts 02472 —
Not listed Flowood Mississippi 39232 —
Not listed O'Fallon Missouri 63368 —
Not listed Albuquerque New Mexico 87131 —
Not listed New York New York 10021 —
Not listed New York New York 10029 —
Not listed New York New York 10032 —
Not listed Rochester New York 14618 —
Not listed Durham North Carolina 27710 —
Not listed Beachwood Ohio 44122 —
Not listed Canton Ohio 44718 —
Not listed Cincinnati Ohio 45215 —
Not listed Cincinnati Ohio 45227 —
Not listed Jenkintown Pennsylvania 19046 —
Not listed Media Pennsylvania 19063 —
Not listed Columbia South Carolina 29201 —
Not listed Arlington Texas 76012 —
Not listed Houston Texas 77030 —
Not listed Salt Lake City Utah 84106 —
Not listed Richmond Virginia 23298 —
Not listed Roanoke Virginia 24014 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01457677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Oct 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01457677 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →